Thoracic & Cardiovascular Healthcare Foundation, Lansing, MI Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2008
NCT00559988
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

clavulanate (Augmentin) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 4)

Embolism (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2